In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
In the latest session, Zai Lab Limited ADR (NASDAQ: ZLAB) closed at $1.23M up 1110946% from its previous closing price of $36.93. In other words, the price has increased by $1110946 from its previous closing price. On the day, 1.11 million shares were traded. ZLAB stock price reached its highest trading level at $35.76 during the session, while it also had its lowest trading level at $34.4421.
Ratios:
For a deeper understanding of Zai Lab Limited ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.09 and its Current Ratio is at 3.26. In the meantime, Its Debt-to-Equity ratio is 0.24 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Scotiabank on March 07, 2025, initiated with a Sector Outperform rating and assigned the stock a target price of $55.
On March 03, 2025, BofA Securities Downgraded its rating to Neutral which previously was Buy and also upped its target price recommendation from $29 to $36.10.
On December 14, 2023, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $47.50.Morgan Stanley initiated its Overweight rating on December 14, 2023, with a $47.50 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 20 ’25 when Lis William bought 13,814 shares for $35.67 per share.
Chen Yajing sold 9,618 shares of ZLAB for $288,540 on Jun 02 ’25. The Chief Financial Officer now owns 17,429 shares after completing the transaction at $30.00 per share. On Jun 02 ’25, another insider, Chen Yajing, who serves as the Officer of the company, bought 9,618 shares for $30.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZLAB now has a Market Capitalization of 3895236096 and an Enterprise Value of 36912934912. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.07 while its Price-to-Book (P/B) ratio in mrq is 4.62. Its current Enterprise Value per Revenue stands at 88.24 whereas that against EBITDA is -144.294.
Stock Price History:
The Beta on a monthly basis for ZLAB is 0.95, which has changed by 0.8426666 over the last 52 weeks, in comparison to a change of 0.09544468 over the same period for the S&P500. Over the past 52 weeks, ZLAB has reached a high of $44.34, while it has fallen to a 52-week low of $16.01. The 50-Day Moving Average of the stock is 6.38%, while the 200-Day Moving Average is calculated to be 17.83%.
Shares Statistics:
For the past three months, ZLAB has traded an average of 1.23M shares per day and 1092050 over the past ten days. A total of 109.84M shares are outstanding, with a floating share count of 109.14M. Insiders hold about 1.31% of the company’s shares, while institutions hold 50.87% stake in the company. Shares short for ZLAB as of 1748563200 were 5109230 with a Short Ratio of 4.17, compared to 1745971200 on 6648753. Therefore, it implies a Short% of Shares Outstanding of 5109230 and a Short% of Float of 5.3000003.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The market rating for Zai Lab Limited ADR (ZLAB) is a result of the insights provided by 6.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.31, with high estimates of -$0.17 and low estimates of -$0.45.
Analysts are recommending an EPS of between -$0.94 and -$1.75 for the fiscal current year, implying an average EPS of -$1.42. EPS for the following year is $0.03, with 10.0 analysts recommending between $0.8 and -$0.97.
Revenue Estimates
A total of 7 analysts believe the company’s revenue will be $126.91M this quarter.It ranges from a high estimate of $132.31M to a low estimate of $113.8M. As of the current estimate, Zai Lab Limited ADR’s year-ago sales were $100.5MFor the next quarter, 7 analysts are estimating revenue of $153.18M. There is a high estimate of $157.9M for the next quarter, whereas the lowest estimate is $148M.
A total of 16 analysts have provided revenue estimates for ZLAB’s current fiscal year. The highest revenue estimate was $591.32M, while the lowest revenue estimate was $551M, resulting in an average revenue estimate of $567.72M. In the same quarter a year ago, actual revenue was $398.99MBased on 15 analysts’ estimates, the company’s revenue will be $846.88M in the next fiscal year. The high estimate is $962M and the low estimate is $715M.
